Tannic acid is an inhibitor of CXCL12 (SDF-1$\alpha$)/CXCR4 with antiangiogenic activity
Clicks: 264
ID: 61484
2003
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Star Article
65.5
/100
264 views
206 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
StarRanked #3 of 7 articles by views in Clinical Cancer Research
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract is not available for this article.
Login to Search Abstract
| Reference Key |
chen2003tannicclinical
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Chen, Xin;Beutler, John A;McCloud, Thomas G;Loehfelm, Amy;Yang, Lu;Dong, Hui-Fang;Chertov, Oleg Y;Salcedo, Rosalba;Oppenheim, Joost J;Howard, OM Zack |
| Journal | Clinical Cancer Research |
| Year | 2003 |
| DOI |
DOI not found
|
| URL | URL not found |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.